Securities code: 000756 securities abbreviation: Shandong Xinhua Pharmaceutical Company Limited(000756) Announcement No.: 2021-83 Shandong Xinhua Pharmaceutical Company Limited(000756)
Announcement on resolutions of the seventh extraordinary meeting of the 10th board of supervisors in 2021
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shandong Xinhua Pharmaceutical Company Limited(000756) (“the company” or “the company”) the notice of the seventh extraordinary meeting of the 10th board of supervisors in 2021 was sent by mail on December 29, 2021, and the meeting was held by written signature on December 31, 2021. There are 5 supervisors who should attend the meeting and 5 supervisors who actually attend the meeting. The convening of the meeting shall comply with the provisions of relevant laws, regulations, rules and the articles of association.
The meeting considered and passed the following proposals and formed the following resolutions:
1、 After deliberating and passing the proposal on the first grant of 2021 A-share stock option to the incentive object, the board of supervisors of the company verified whether the incentive object determined in the 2021 A-share stock option incentive plan (Draft) (hereinafter referred to as “this incentive plan” or “incentive plan (Draft)”) meets the grant conditions, and the board of supervisors considered that:
The personnel listed in the list of the company’s incentive plan for the first time comply with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of equity incentive of listed companies, and the Trial Measures for the implementation of equity incentive by state-controlled listed companies (within China) The scope and qualifications of incentive objects specified in the notice on issues related to regulating the implementation of equity incentive system by state-controlled listed companies and other laws, regulations and normative documents, as well as the articles of association and the company’s incentive plan (Draft), In addition, the incentive objects do not have the following circumstances that may not be incentive objects as mentioned in Article 8 of the measures for the administration of equity incentive of listed companies:
1. Being identified as inappropriate by the stock exchange within the last 12 months;
2. It has been identified as an inappropriate candidate by the CSRC and its dispatched offices within the last 12 months;
3. Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations within the last 12 months;
4. Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law;
5. Those who are not allowed to participate in equity incentive of listed companies according to laws and regulations;
6. Other circumstances recognized by the CSRC.
The personnel listed in the first award list of the company’s incentive plan are legal and effective as the subject qualification of the incentive object of the company’s incentive plan. At the same time, the grant conditions of this incentive plan have been met, and it is agreed that the company will grant 23.15 million stock options to 196 eligible incentive objects on December 31, 2021 as the first grant date.
Voting results: 5 persons agreed, accounting for 100% of the total number of supervisors of the company; 0 against and 0 abstention. The proposal on granting 2021 A-share stock options to incentive objects for the first time is published on cninfo.com on the same day（ http://www.cn.info.com..cn. ）Relevant announcements.
Documents for future reference
1. Resolution of the seventh extraordinary meeting of the 10th board of supervisors in 2021.
It is hereby announced.
Shandong Xinhua Pharmaceutical Company Limited(000756) board of supervisors December 31, 2021
